MDMiaomiao Dai

Miaomiao Dai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miaomiao Dai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Ouyang

    Department of Joint Surgery, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), No.1 Jiazi Road, Lunjiao, Shunde District, Foshan City, Guangdong Province, China

    3 shared publications
  • Yi Ouyang

    Department of Joint Surgery, Shunde Hospital, Southern Medical University (The First People’s Hospital of Shunde, Foshan), Foshan City, China

    2 shared publications
  • Guoteng Tang

    School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang 212003, PR China

    1 shared publication
  • Huazhe Jiao

    School of Civil Engineering, Henan Polytechnic University, Jiaozuo 454003, PR China

    1 shared publication
  • Tongyi Yang

    School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang 212100, China

    1 shared publication
  • Weisheng Hong

    Department of Joint Surgery Shunde Hospital Southern Medical University (The First People's Hospital of Shunde, Foshan), No. 1 Jiazi Road, Lunjiao, Shunde District, Foshan City, Guangdong Province, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Global, regional, and national burden of knee osteoarthritis: findings from the Global Burden of Disease study 2021 and projections to 2045

    by Yi Ouyang, Miaomiao Dai

    Osteoarthritis is a major contributor to the global disease burden, with the knee being the most commonly affected site. Comprehensive research on knee osteoarthritis (KOA) at a global scale carries significant implications for public health. The estimates and 95% uncertainty intervals (UIs) for prevalence, incidence and disability-adjusted life years (DALYs) of KOA were extracted from Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. We described KOA epidemiology at global, regional, and national levels, analyzed 1990-2021 trends in KOA burden from overall, local, and multi-dimension scopes, decomposed KOA burden according to population size, age structure, and epidemiologic changes, quantified cross-country inequalities in KOA burden using standard health equity methods recommended by World Health Organization, and predicted changes of KOA burden to 2045. GBD 2021 estimated 374,738,744 (95% UI: 321,858,982-428,353,220) prevalent cases, 30,845,891 (95% UI: 26,534,151-35,188,905) incident cases and 12,019,070 (95% UI: 67.08-266.87) DALYs cases of KOA worldwide in 2021. An overall increase in prevalence rates, incidence rates and DALYs rates were observed from 1990 to 2021. And the prevalence number, incidence number and rates were consistently higher in females compared to males. Decomposition analysis revealed that aging, population growth, and epidemiological changes contributed 15.6%, 74.72%, and 9.69% to the global increase in age-standardized prevalence rate, respectively. A decrease in Socio-Demographic Index (SDI)-related inequalities was detected. Notably, the case number of these metrics were predicted to keeping increasing, with predicted values of 658,088,384.48 (322,110,040.98-994,066,727.98), 47,256,502.97 (23,440,017.7-71,072,988.23) and 20,517,479.78 (10,056,930.68-30,978,028.88), respectively. The global burden of KOA has shown a consistent upward trend from 1990 to 2021, primarily driven by population growth and aging demographics. Countries with high SDI faced a disproportionately high burden of KOA, although inequalities related to SDI among nations have decreased over time. This study underscores significant challenges in managing KOA, including the increasing number of cases and ongoing disparities worldwide.


  • Open Access

    Global, regional, and national burden of refraction disorders: findings from the global burden of disease study 2021 and projections to 2050

    by Miaomiao Dai, Yi Ouyang

    Refraction disorders are the leading cause of visual impairment worldwide. This study investigates the global burden and trends of refraction disorders from 1990 to 2021, with projections extending to 2050. Data on prevalence and disability-adjusted life years (DALYs) for refraction disorders, along with their 95% uncertainty intervals (UIs), were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. The study provides a comprehensive analysis of the epidemiology of refraction disorders at global, regional, and national levels. It examines trends from 1990 to 2021 from multiple dimensions, including overall and localized changes. Burden decomposition was performed to assess contributions from population size, age structure, and epidemiological changes. Cross-country inequalities were quantified using standard health equity methods recommended by the World Health Organization. Future changes in the burden of refraction disorders were also projected through 2050. According to GBD 2021 estimates, there were 159,765,917 prevalent cases (95% UI: 142,526,915–178,698,348) and 6,618,600 DALYs (95% UI: 4,599,082–9,528,676) due to refraction disorders globally in 2021. From 1990 to 2021, prevalence and DALYs rates demonstrated a steady decline, although prevalence numbers, incidence numbers, and rates were consistently higher among females compared to males. Decomposition analysis showed that aging, population growth, and epidemiological changes contributed 36.25%, 76.92%, and − 13.18%, respectively, to changes in the age-standardized prevalence rate (ASR). The concentration index declined from − 0.17 (95% CI: −0.21 to − 0.13) in 1990 to − 0.10 (95% CI: −0.13 to − 0.07) in 2021, indicating a reduction in SDI-related inequalities. By 2050, the ASR for prevalence and DALYs is projected to decline to 1815.27 (95% UI: 534.15–3096.40) and 69.11 (95% UI: 21.45–116.77), respectively. The global burden of refraction disorders decreased significantly from 1990 to 2021 and is expected to decline further by 2050. Females continue to experience a greater burden compared to males. Population growth emerged as the primary driver of changes in the ASR of prevalence and DALYs. While countries with low socio-demographic index (SDI) face a disproportionately high burden, SDI-related inequalities have gradually lessened over time.


  • Open Access

    Causal relationships between systemic inflammatory cytokines and adhesive capsulitis: a bidirectional Mendelian randomization study

    by Yi Ouyang, Miaomiao Dai

    Background: Mounting evidence suggests a connection between inflammatory cytokines and adhesive capsulitis (AC). However, the specific systemic inflammatory cytokines contributing to AC have not been clearly identified. This study employed Mendelian randomization (MR) to explore the causal relationships between 41 inflammatory cytokines and AC.Methods: In this bidirectional, two-sample MR analysis, genetic variations associated with AC were derived from a comprehensive genome-wide association study (GWAS). The inflammatory cytokines data were sourced from a GWAS summary involving 8,293 healthy participants. The primary MR method employed was inverse variance weighting, supplemented by MR-Egger, weighted median, and MR-pleiotropy residual sum and outlier for sensitivity analysis. Heterogeneity was assessed using Cochran’s Q test, and the MR results were validated using the leave-one-out method.Results: Elevated levels of interferon gamma-induced protein 10 (IP-10) (odds ratio (OR) = 1.086, 95% confidence interval (CI) = 1.002–1.178) and regulated on activation, normal T cell expressed and secreted (RANTES) (OR = 1.107, 95% CI = 1.026–1.195) were linked to an increased risk of AC. Increased levels of stromal cell-derived factor-1 alpha (SDF-1α) (OR = 0.879, 95% CI = 0.793–0.974) and tumor necrosis factor-alpha (TNF-α) (OR = 0.911, 95% CI = 0.831–0.999) were associated with a reduced AC risk. Moreover, genetically predicted AC exhibited associations with elevated cutaneous T cell attracting (CTACK) levels (OR = 1.202, 95% CI = 1.007–1.435) and diminished levels of interleukin-17 (IL-17) (OR = 0.678, 95% CI = 0.518–0.888) and interleukin-5 (IL-5) (OR = 0.786, 95% CI = 0.654–0.944), as confirmed through inverse-variance weighted (IVW) methods.Conclusion: The present study successfully establishes a causal association between genetically proxied circulating levels of IP-10, RANTES, SDF-1α, and TNF-α and the risk of AC. Additionally, AC contributes to an increase in CTACK and a decrease in IL-17 and IL-5. This significant finding not only enhances the understanding of the pathogenesis of AC but also holds promise for the development of effective clinical management strategies.


  • Effect of an electro-assisted biochemical cycle reactor on bio-oxidation of gold ore

    by Tongyi Yang, Miaomiao Dai, Guoteng Tang, Zechong Guo, Yixuan Yang, Huazhe Jiao


  • Open Access

    Anxiety disorders and adhesive capsulitis: a bidirectional Mendelian randomization study

    by Yi Ouyang, Miaomiao Dai

    Background: Previous epidemiological investigations and related research efforts consistently have outlined an observable association between anxiety disorders and adhesive capsulitis (AC). However, the intricate nature of the causal connection between these entities has yet to be fully clarified. Therefore, this investigative study aims to thoroughly examine and delineate the causal interrelationship between anxiety disorders and AC using a bidirectional, two-sample Mendelian randomization (MR) approach.Methods: To pursue this inquiry, datasets related to anxiety disorders and AC were meticulously obtained from a publicly accessible genomewide association study. Instrumental variables, in the form of single nucleotide polymorphisms, were subsequently identified, undergoing a rigorous screening process that included intensity adjustment and the amelioration of linkage disequilibrium. The primary analytical tool for scrutinizing causal ramifications was the inverse variance weighting (IVW) methodology, complemented by supplementary analytical techniques such as weighted median, MR-Egger, simple mode, and weighted mode. Additionally, evaluations of heterogeneity and pleiotropy were meticulously conducted. Heterogeneity was assessed using Cochran’s Q-test in conjunction with the IVW and MR-Egger methods, while pleiotropy was appraised through the MR-Egger intercept and MR-PRESSO analysis methods. A leave-one-out analysis was undertaken to enhance the reliability of our findings. Finally, AC was utilized to infer reverse causality concerning the risk of anxiety disorders.Results: The random effects IVW analysis results yielded statistical significance (P = 9.362 × 10-6), demonstrating a causal link between anxiety disorders and elevated susceptibility to AC, reflected in an odds ratio of 1.267 (95% confidence interval: 1.141–1.407). Conversely, the inverse MR analysis predominantly produced null findings. Furthermore, sensitivity analyses underscored the robustness of our conclusions.Conclusion: In summary, our meticulously conducted study unequivocally supports the presence of a causal connection between anxiety disorders and an increased propensity for AC. Unfortunately, the reverse MR analysis failed to provide compelling evidence indicative of a reciprocal genetic causative relationship between AC and anxiety disorders.


  • Open Access

    Identification and Validation of Hub Genes and Construction of miRNA‐Gene and Transcription Factor‐Gene Networks in Adipogenesis of Mesenchymal Stem Cells

    by Miaomiao Dai, Weisheng Hong, Yi Ouyang

    Background. Adipogenic differentiation stands as a crucial pathway in the range of differentiation options for mesenchymal stem cells (MSCs), carrying significant importance in the fields of regenerative medicine and the treatment of conditions such as obesity and osteoporosis. However, the exact mechanisms that control the adipogenic differentiation of MSCs are not yet fully understood. Materials and Methods. We procured datasets, namely GSE36923, GSE80614, GSE107789, and GSE113253, from the Gene Expression Omnibus database. These datasets enabled us to perform a systematic analysis, including the identification of differentially expressed genes (DEGs) pre‐ and postadipogenic differentiation in MSCs. Subsequently, we conducted an exhaustive analysis of DEGs common to all four datasets. To gain further insights, we subjected these overlapped DEGs to comprehensive gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Following the construction of protein–protein interaction (PPI) networks, we meticulously identified a cohort of hub genes pivotal to the adipogenic differentiation process and validated them using real‐time quantitative polymerase chain reaction. Subsequently, we ventured into the construction of miRNA‐gene and TF–gene interaction networks. Results. Our rigorous analysis revealed a total of 18 upregulated DEGs and 12 downregulated DEGs that consistently appeared across all four datasets. Notably, the peroxisome proliferator‐activated receptor signaling pathway, regulation of lipolysis in adipocytes, and the adipocytokine signaling pathway emerged as the top‐ranking pathways significantly implicated in the regulation of these DEGs. Subsequent to the construction of the PPI network, we identified and validated 10 key node genes, namely IL6, FABP4, ADIPOQ, LPL, PLIN1, RBP4, ACACB, NT5E, KRT19, and G0S2. Our endeavor to construct miRNA–gene interaction networks led to the discovery of the top 10 pivotal miRNAs, including hsa‐mir‐27a‐3p, hsa‐let‐7b‐5p, hsa‐mir‐1‐3p, hsa‐mir‐124‐3p, hsa‐mir‐155‐5p, hsa‐mir‐16‐5p, hsa‐mir‐101‐3p, hsa‐mir‐21‐3p, hsa‐mir‐146a‐5p, and hsa‐mir‐148b‐3p. Furthermore, the construction of TF–gene interaction networks revealed the top 10 critical TFs: ZNF501, ZNF512, YY1, EZH2, ZFP37, ZNF2, SOX13, MXD3, ELF3, and TFDP1. Conclusions. In summary, our comprehensive study has successfully unraveled the pivotal hub genes that govern the adipogenesis of MSCs. Moreover, the meticulously constructed miRNA‐gene and TF–gene interaction networks are poised to significantly augment our comprehension of the intricacies underlying MSC adipogenic differentiation, thus providing a robust foundation for future advances in regenerative biology.


  • Open Access

    Screening for genes, miRNAs and transcription factors of adipogenic differentiation and dedifferentiation of mesenchymal stem cells

    by Yi Ou-Yang, Miao-Miao Dai

    Background: The purpose of present study was to reveal the molecular mechanisms responsible for both adipogenic differentiation and dedifferentiation of mesenchymal stem cells (MSCs). Methods: Microarray data GSE36923 were obtained from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between adipogenically differentiated cells vs undifferentiated bone marrow-derived MSCs, adipogenically differentiated cells vs dedifferentiated cells samples at day 7 and adipogenically differentiated cells vs dedifferentiated cells samples at day 35 were screened, and overlapped DEGs across the three groups were analyzed. The underlying functions of the upregulated and downregulated DEGs were investigated by Gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analysis. The protein–protein interaction network was constructed, and hub genes were obtained subsequently. Hub genes were verified with GSE113253 dataset, and then miRNA-gene network and TF-gene network were constructed. Results: A total of 284 upregulated DEGs and 376 downregulated DEGs overlapped across the three groups. PPAR signaling pathway, AMPK signaling pathway, insulin signaling pathway, carbon metabolism, pyruvate metabolism, fatty acid metabolism, regulation of lipolysis in adipocytes, biosynthesis of amino acids, citrate cycle (TCA cycle) and 2-Oxocarboxylic acid metabolism were the top 10 pathways involving in the upregulated DEGs, and graft-versus-host disease, allograft rejection, viral myocarditis, cell adhesion molecules, phagosome, type I diabetes mellitus, antigen processing and presentation, autoimmune thyroid disease, intestinal immune network for IgA production and rheumatoid arthritis were the top 10 pathways in downregulated DEGs. After validation, the 8 hub genes were IL6, PPARG, CCL2, FASN, CEBPA, ADIPOQ, FABP4 and LIPE. Ten key miRNAs were hsa-mir-27a-3p, hsa-mir-182-5p, hsa-mir-7-5p, hsa-mir-16-5p, hsa-mir-1-3p, hsa-mir-155-5p, hsa-mir-21-3p, hsa-mir-34a-5p, hsa-mir-27a-5p and hsa-mir-30c-5p, and 10 key TFs were TFDP1, GTF2A2, ZNF584, NRF1, ZNF512, NFRKB, CEBPG, KLF16, GLIS2 and MXD4. Conclusion: Our study constructed miRNA-gene network and TF-gene network involved in both adipogenic differentiation and dedifferentiation of MSCs, contributing to enhancing the efficiency of MSCs transplantation in soft tissue defect repair and developing more potent remedies for adipogenesis-related skeletal disorders.